No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
110 |
4. Check minimum number of eventsNone |
110 |
5. Include endpointsNone |
110 |
6. Filter based on genotype QC (FinnGen only) |
104 |
Control definitions (FinnGen only)
- Control exclude
- E4_NUTRIDEF
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E61
- Name in latin
- Deficientia magnesii
Similar endpoints
↥List of similar endpoints to
Magnesium deficiency
based on the number of shared cases.
Similar with more cases:
- Other nutritional deficiencies
- Endocrine, nutritional and metabolic diseases
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 425 | 193 | 228 |
| Only index persons | 408 | 188 | 220 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 65.03 | 66.98 | 63.78 |
| Only index persons | 65.36 | 67.07 | 63.90 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 104 | 53 | 51 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 66.35 | 67.57 | 65.08 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 110
- Matched controls
- 1100
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E61.2
ICD-10 Finland
Magnesium deficiency
+∞
158.7
110
*
E87.6
ICD-10 Finland
Hypokalaemia
38.7
59.6
40
16
A49.9
ICD-10 Finland
Bacterial infection, unspecified
10.3
29.5
42
62
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
8.8
29.5
56
116
E83.51
ICD-10 Finland
Hypocalcemia
176.8
27.0
27
*
A03FA01
ATC
metoclopramide; systemic, rectal
6.5
21.7
59
167
TPH04
NOMESCO Finland
Cathetrisation of vein
6.1
19.9
55
156
Z51.5
ICD-10 Finland
Palliative care
8.8
18.8
27
39
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
9.1
18.7
26
36
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
9.2
18.2
25
34
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
6.0
17.6
42
103
TPH07
NOMESCO Finland
Cathetrisation of artery
6.6
17.3
35
73
E83.4
ICD-10 Finland
Disorders of magnesium metabolism
+∞
17.1
16
*
AA1AD
NOMESCO Finland
CT of head and brain
5.2
16.9
58
193
JN4AD
NOMESCO Finland
Body CT examination
6.2
15.4
32
68
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
6.7
15.4
29
56
WX408
NOMESCO Finland
General anesthesy, balanced
4.9
15.3
53
175
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
7.1
14.9
26
46
WX892
NOMESCO Finland
Monitored bed care
7.4
14.6
24
40
JN3AD
NOMESCO Finland
Abdominal CT examination
6.0
14.4
31
68
H02AB02
ATC
dexamethasone; systemic
5.5
14.3
35
86
D64.9
ICD-10 Finland
Anaemia, unspecified
6.4
14.3
28
56
N02AA05
ATC
oxycodone; systemic
4.7
13.8
45
140
130
Kela drug reimbursment
Malignant tumour
5.9
13.5
29
63
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.6
13.4
31
72
R4190
NOMESCO Finland
Nutritional therapy
14.9
13.3
22
18
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.7
13.1
78
377
WW500
NOMESCO Finland
Blood transfusion
12.3
12.8
23
23
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.3
12.2
46
158
C03CA01
ATC
furosemide; systemic
4.2
12.0
49
178
ZX120
NOMESCO Finland
Intravenous
5.8
11.9
25
53
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.0
11.6
54
214
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
12.1
11.6
21
21
R11
ICD-10 Finland
Nausea and vomiting
6.1
11.6
23
46
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.6
11.2
20
36
A04AA02
ATC
granisetron; systemic, transdermal
6.0
11.1
22
44
C03DA01
ATC
spironolactone; oral
5.3
11.0
26
61
215
Kela drug reimbursment
Diabetes, non-insulin-treated
3.8
10.0
43
159
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
9.5
9.9
20
25
TKC20
NOMESCO Finland
Catheterisation of bladder
6.0
9.8
19
37
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
4.4
9.7
29
82
ZXE00
NOMESCO Finland
One hour or less
3.5
9.7
61
287
WX882
NOMESCO Finland
High dependency care
19.8
9.7
14
8
E55.9
ICD-10 Finland
Vitamin D deficiency, unspecified
109.0
9.6
10
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
9.7
9.5
19
23
E53.8
ICD-10 Finland
Deficiency of other specified B group vitamins
+∞
9.5
9
*
A04AA01
ATC
ondansetron; systemic, rectal
5.0
9.5
23
55
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
4.4
9.4
28
79
103
Kela drug reimbursment
Diabetes, insulin-treated
3.6
9.4
43
165
J01MA02
ATC
ciprofloxacin; systemic
3.4
9.4
62
300
B03BA03
ATC
hydroxocobalamin; parenteral
9.3
9.3
19
24
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
14.2
9.2
15
12
R53
ICD-10 Finland
Malaise and fatigue
3.6
9.2
42
161
JDB10
NOMESCO Finland
Percutaneous gastrostomy
26.6
9.1
12
5
J01MA12
ATC
levofloxacin; systemic
3.8
9.1
35
119
R56.8
ICD-10 Finland
Other and unspecified convulsions
9.5
9.0
18
22
A01
ICPC
Pain general/multiple sites
4.9
8.9
22
53
UJF32
NOMESCO Finland
Coloscopy
3.5
8.9
44
177
B01AB10
ATC
tinzaparin; parenteral
4.5
8.8
25
68
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.2
8.3
57
277
E86
ICD-10 Finland
Volume depletion
19.0
8.3
12
7
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.4
8.2
39
152
N02AX02
ATC
tramadol; systemic, rectal
3.2
8.1
66
353
C07AB07
ATC
bisoprolol; oral
3.2
7.9
72
408
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
48.6
7.8
9
*
XF600
NOMESCO Finland
Bloodpressure measurement
6.9
7.8
19
32
R4110
NOMESCO Finland
Physiotherapy
3.1
7.8
50
232
N03AX16
ATC
[U] pregabalin
3.3
7.7
39
157
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.9
7.6
26
81
WF004
NOMESCO Finland
Palliative radiotherapy
12.1
7.5
13
12
A02BC02
ATC
pantoprazole; systemic
4.1
7.5
93
626
K92.1
ICD-10 Finland
Melaena
7.5
7.5
17
26
XF400
NOMESCO Finland
ECG with 12 standard connections
3.5
7.4
31
110
NE1AA
NOMESCO Finland
Pelvis X-ray examination
4.8
7.3
18
43
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
32.4
7.3
9
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.9
7.2
25
78
Z3231
NOMESCO Finland
Registered nurse
3.0
7.1
44
198
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
7.0
7.1
17
28
SPAT1262
SPAT
Handing over of treatment supplies
3.7
7.1
27
90
N17.9
ICD-10 Finland
Acute renal failure, unspecified
9.3
7.1
14
17
F10.25
ICD-10 Finland
Alcohol dependence continuous use
15.1
7.1
11
8
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.8
7.0
17
40
R55
ICD-10 Finland
Syncope and collapse
4.0
6.8
22
65
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
4.0
6.8
22
65
JN4BD
NOMESCO Finland
Extensive body CT
3.7
6.8
25
81
WX402
NOMESCO Finland
General anaesthesia
3.1
6.7
37
155
A28
ICPC
Limited function/disability NOS
3.4
6.7
29
105
WX302
NOMESCO Finland
Thoracal epidural anesthesy
6.7
6.6
16
27
WZC00
NOMESCO Finland
Treatment plan or consultation
2.8
6.5
56
298
Z3226
NOMESCO Finland
Physiotherapist
3.1
6.5
34
138
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.2
6.4
32
126
N05AH04
ATC
quetiapine; oral
3.3
6.4
29
108
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
19.4
6.4
9
5
E83.50
ICD-10 Finland
Hypercalcemia
28.5
6.3
8
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
9.5
6.2
12
14
L28
ICPC
Limited function/disability (L)
3.3
6.2
28
104
N30.0
ICD-10 Finland
Acute cystitis
3.6
6.1
23
76
I50.9
ICD-10 Finland
Heart failure, unspecified
3.6
6.0
22
71
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
76
112
19.72
57.76
9.5
6.7
0.97
1.05
mmol/l
0.78
76
105
49
74
11.14
34.31
5.9
4.6
2.18
2.26
mmol/l
0.04
43
60
45
61
11.79
34.21
2.2
1.7
—
—
—
0
0
40
49
12.26
32.62
10.8
7.1
24.43
25.45
mmol/l
0.59
40
49
105
470
28.09
29.40
22.7
7.8
1.17
1.21
mmol/l
4.01
91
402
44
72
9.52
28.36
4.2
4.1
96.03
88.23
ng/l
0.15
36
64
50
95
8.82
28.31
4.5
2.4
413.36
396.71
nmol/l
0.21
44
90
70
195
8.12
27.32
3.1
1.9
2.92
3.49
mg/l
0.70
62
171
99
401
15.69
26.33
13.9
4.7
32.05
35.38
g/l
5.70
99
379
55
126
7.73
25.84
13.9
7.7
102.20
103.83
mmol/l
0.94
55
126
45
96
7.24
22.27
5.4
2.0
29.91
29.04
u/l
0.09
45
85
103
547
14.85
20.84
23.4
11.4
4.31
4.04
e9/l
0.60
86
480
79
330
5.95
17.61
5.9
3.1
—
—
—
0
0
45
118
5.76
17.46
13.4
8.3
-0.63
1.52
mmol/l
1.61
40
95
33
65
6.82
17.28
16.9
9.5
94.68
94.60
%
0.06
33
65
70
272
5.33
16.83
5.2
2.8
0.79
0.37
e6/l
0.68
51
197
53
166
5.23
16.59
9.7
3.5
2.46
2.47
mmol/l
0.17
48
144
26
42
7.80
16.31
3.6
2.6
0.56
0.62
%
0.37
26
42
42
112
5.45
15.81
2.5
1.5
—
—
—
0
0
61
224
4.87
15.45
4.1
2.4
—
—
—
0
0
51
166
4.86
14.98
4.3
2.7
0.98
1.02
e6/l
0.04
26
90
42
117
5.19
14.92
2.7
1.6
—
—
—
0
0
49
156
4.86
14.77
5.7
2.8
4.37
2.16
e6/l
0.65
25
81
31
69
5.86
14.12
17.9
9.0
0.61
0.69
%
0.37
31
69
46
149
4.59
13.37
2.9
1.7
—
—
—
0
0
84
433
4.98
12.80
15.8
11.2
1.24
1.17
inr
0.37
24
120
86
453
5.12
12.68
4.6
2.5
—
—
—
0
0
74
352
4.37
12.48
3.5
1.8
81.91
98.00
pmol/l
1.41
50
153
36
102
4.76
12.29
2.6
1.8
1.94
1.68
%
0.44
25
93
29
69
5.35
12.16
18.9
9.0
1.23
1.48
%
0.74
29
69
37
110
4.56
11.85
7.2
4.4
6.48
12.29
ug/l
0.64
31
91
46
165
4.07
11.39
2.1
1.6
1059.91
1208.29
nmol/l
0.59
35
122
47
174
3.97
11.09
9.7
3.3
78.98
111.59
ng/l
0.32
41
143
23
48
5.79
11.06
2.3
1.7
—
—
—
0
0
20
21
11.37
10.81
1.6
1.4
—
—
—
0
0
21
46
5.41
9.53
1.6
1.6
—
—
—
0
0
58
269
3.45
9.40
3.6
3.1
2843.92
1065.72
ng/l
1.60
48
225
28
82
4.24
8.94
7.7
3.4
—
—
—
0
0
47
200
3.36
8.61
2.4
1.7
1.34
1.13
mg/l
0.32
42
159
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
28
6.98
7.11
3.6
1.9
0.42
0.38
u/ml
—
10
14
14
19
8.27
6.65
1.1
1.2
—
—
—
0
0
98
708
4.52
6.55
8.0
3.9
23.39
11.79
mm/h
5.30
93
645
17
43
4.49
6.44
6.6
4.0
1.74
1.61
mmol/l
0.02
11
36
51
266
2.71
6.09
4.7
3.6
17.74
7.54
mg/mmol
0.67
35
159
11
13
9.25
5.71
3.9
2.5
55.09
56.08
%
0.05
11
13
8
5
17.08
5.49
1.0
1.0
1.78
1.46
g/l
—
8
5
11
14
8.59
5.49
2.8
1.4
14.27
17.44
%
—
6
7
70
445
2.58
5.35
8.1
5.1
0.00
0.00
estimate
-0.00
15
84
110
971
+∞
5.32
70.9
15.8
138.03
139.73
mmol/l
6.78
110
945
70
446
2.57
5.31
5.9
3.7
0.00
0.00
estimate
-0.00
17
84
10
12
9.03
5.18
3.6
2.1
4.67
4.08
e9/l
—
10
12
9
9
10.76
5.13
1.8
2.0
14.71
16.78
ug/l
—
9
9
70
453
2.50
5.03
5.9
3.7
0.00
0.00
estimate
-0.00
16
79
13
25
5.75
4.95
1.5
1.6
—
—
—
0
0
11
17
7.06
4.91
1.9
1.1
—
—
—
0
0
11
17
7.06
4.91
1.9
1.1
—
—
—
0
0
103
856
4.19
4.67
7.4
4.5
1.98
1.97
mu/l
0.01
93
767
7
5
14.81
4.64
1.0
1.0
—
—
—
0
0
11
19
6.30
4.57
2.3
1.9
4.69
5.79
mmol/24h
0.26
11
19
11
20
5.98
4.42
2.1
1.3
—
—
—
0
0
14
41
3.77
4.35
5.8
4.8
26.79
24.60
mmol/l
1.14
14
41
90
682
2.76
4.23
6.1
3.9
15.07
14.79
pmol/l
0.40
84
610
8
10
8.52
4.13
1.0
1.0
—
—
—
0
0
110
1001
+∞
4.10
66.1
16.3
79.05
77.21
umol/l
0.28
110
1001
35
179
2.40
4.09
2.2
1.7
451.82
460.81
pmol/l
0.05
28
149
10
18
5.99
4.08
5.6
2.6
23.18
25.08
mmol/l
—
10
18
12
28
4.68
3.95
1.8
1.9
—
—
—
0
0
56
364
2.10
3.56
6.7
3.5
63.91
39.22
ng/l
0.32
47
252
11
27
4.41
3.50
1.3
1.9
—
—
—
0
0
8
14
6.07
3.41
1.0
1.3
—
—
—
0
0
84
644
2.29
3.39
7.7
2.9
136.83
45.27
u/l
2.71
77
604
12
34
3.83
3.32
1.4
1.2
—
—
—
0
0
10
24
4.47
3.28
1.2
1.2
—
—
—
0
0
43
260
2.07
3.25
3.5
2.8
332.64
8223.19
umol/l
1.53
36
223
12
35
3.72
3.22
1.4
1.2
—
—
—
0
0
8
16
5.30
3.11
1.3
1.6
—
—
—
0
0
5
5
10.38
3.01
1.6
4.2
68.20
66.00
nmol/l
—
5
5
12
38
3.42
2.96
5.0
1.4
—
—
—
0
0
12
39
3.33
2.88
7.4
5.3
1.72
1.50
mmol/l
0.22
12
39
30
165
2.13
2.86
1.4
1.2
42.57
21.64
iu/ml
—
9
58
7
14
5.26
2.77
1.4
1.9
—
—
—
0
0
7
14
5.26
2.77
1.4
1.9
—
—
—
0
0
9
24
3.99
2.74
1.1
2.2
—
—
—
0
0
101
881
2.79
2.71
55.8
12.8
81.40
81.42
ml/min/173m2
0.00
90
704
13
50
2.81
2.64
1.5
1.3
—
—
—
0
0
9
25
3.82
2.64
1.9
1.3
—
—
—
0
0
6
11
5.70
2.58
1.3
1.8
—
—
—
0
0
96
815
2.40
2.48
66.3
16.8
15.41
15.23
%
0.14
96
807
9
27
3.54
2.45
1.2
1.1
—
—
—
0
0
6
12
5.22
2.43
1.0
1.4
—
—
—
0
0
10
33
3.23
2.43
1.7
2.5
—
—
—
0
0
6
13
4.81
2.30
2.7
2.4
—
—
—
0
0
6
13
4.81
2.30
1.3
1.2
—
—
—
0
0
5
9
5.76
2.23
1.2
1.2
—
—
—
0
0
7
19
3.86
2.19
1.4
2.3
—
—
—
0
0
7
19
3.86
2.19
3.4
1.6
—
—
—
0
0
7
19
3.86
2.19
1.4
2.3
—
—
—
0
0
6
14
4.47
2.18
1.2
1.1
—
—
—
0
0
34
214
1.85
2.18
1.5
1.2
1.00
1.32
u/ml
—
6
50
7
20
3.66
2.09
1.1
2.0
—
—
—
0
0
110
1048
+∞
1.94
76.5
20.5
118.13
136.83
g/l
24.12
110
1033
110
1047
+∞
1.93
76.0
20.5
3.96
4.53
e12/l
19.02
110
1015
7
24
3.04
1.75
1.6
1.3
—
—
—
0
0
7
26
2.80
1.61
1.1
1.6
—
—
—
0
0
6
20
3.11
1.60
1.2
1.7
—
—
—
0
0
6
20
3.11
1.60
1.0
1.4
—
—
—
0
0
6
21
2.96
1.53
1.3
1.8
—
—
—
0
0
5
17
3.03
1.37
1.4
1.7
—
—
—
0
0
13
69
2.00
1.35
3.6
3.7
47.94
61.48
ml/min/173m2
—
8
31
8
35
2.38
1.30
10.4
3.7
4.16
3.91
mmol/l
—
8
35
5
18
2.86
1.30
1.4
1.8
—
—
—
0
0
5
21
2.44
1.10
1.4
1.8
—
—
—
0
0
97
890
1.76
1.09
7.8
5.3
40.92
39.53
mmol/mol
0.58
88
820
9
46
2.04
1.06
9.9
2.8
0.21
0.09
e6/l
—
9
46
0
32
0.00
0.97
0.0
1.6
—
—
—
0
0
43
347
1.39
0.88
7.1
3.9
—
—
—
0
0
63
558
1.30
0.64
3.2
2.8
—
—
—
0
0
5
30
1.70
0.62
1.6
1.1
—
—
—
0
0
29
243
1.26
0.44
8.2
3.9
0.00
0.00
estimate
-0.00
14
80
18
223
0.77
0.41
2.5
2.8
0.40
0.76
ug/l
4.15
13
143
89
927
0.79
0.36
4.8
4.1
1.60
1.28
mmol/l
1.45
78
846
94
970
0.79
0.31
5.5
5.1
2.30
2.78
mmol/l
5.26
84
889
92
950
0.81
0.28
5.0
4.5
1.34
1.49
mmol/l
2.30
82
870
15
125
1.23
0.24
17.7
8.2
—
—
—
0
0
95
924
1.21
0.22
5.6
4.5
6.29
5.92
mmol/l
1.34
88
842
0
10
0.00
0.21
0.0
2.3
—
13.87
—
0
10
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
5
69
0.71
0.17
1.8
1.6
—
—
—
0
0
27
295
0.89
0.16
3.7
4.2
17.75
22.89
%
—
10
136
94
954
0.90
0.09
4.9
4.6
4.22
4.70
mmol/l
4.00
84
880
14
127
1.12
0.08
1.9
1.3
—
—
—
0
0
9
86
1.05
0.07
1.8
2.0
14.01
15.71
nmol/l
—
9
79
35
365
0.94
0.07
3.5
4.4
1.51
1.86
ug/l
0.65
30
323
13
129
1.01
0.00
1.5
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
10.20
—
0
5
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
56.00
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
7
76
0.92
-0.00
1.7
1.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint E4_MG_DEF and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have E4_MG_DEF.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: E4_MG_DEF – Magnesium deficiency
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data